Published Date: 26 Apr 2023
According to research, shyness is defined as a fear and nervousness reaction to social novelty and/or social evaluation. Shyness can show up on the behavioral, affective, and physiological levels, but.
Read Full NewsUltragenyx seeks FDA accelerated approval for UX111 gene therapy in Sanfilippo syndrome, citing neurologic benefit and the use of cerebral spinal fluid heparan sulfate data.
Here's some of what is coming soon to NeurologyLive® this week.
AGNOS trial showed that monthly treatment with ofatumumab lowered NfL and GFAP in patients with early RRMS, signaling reduced nerve damage and bolstering first-line treatment potential.
Pediatric neurologist Charuta Joshi, MD, discussed global disparities in epilepsy for children and adolescents amid International Epilepsy Day, highlighting opportunities for education, stigma reduction, and improved care access.
The FDA issued a CRL for gene therapy RGX-121 in Hunter syndrome, citing trial design and biomarker doubts; Regenxbio seeks a meeting with the agency and resubmission.
In this interview, Siegel highlights key points presented in his Maui Derm 2026 talk, 'How To Maximize Your Billing Effectiveness in the Era of Dwindling Reimbursements and ICD-10.'
New Phase 3 Findings Support Ameluz-PDT for Patients with Actinic Keratosis
1.
AI-based breast cancer risk technology receives FDA breakthrough device designation
2.
Scientists are investigating the prevention of recurrent breast cancer, which frequently results in death.
3.
Universal screening approach achieves a comparable detection rate of lung cancer
4.
Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA.
5.
Enhanced access for patients with prostate cancer is provided by the new SPECT/CT technique, which demonstrates remarkable biomarker identification.
1.
A Revolutionary Guide to Calculating Absolute Neutrophil Counts
2.
Thyroidectomy & Survival: Highlights from ASCO 2025 and Current U.S. Findings
3.
Case Study: Personalized Medicine Based on Genetic Profiling in Oncology
4.
Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer
5.
A New Hope: Exploring the Benefits of Exenteration for Cancer Patients
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
4.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation